PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
16-Jul-2025 Yourgene Health Launches LightBench Discover Yourgene Health
16-Jul-2025 RNA-Based Therapeutics and Vaccines Market Set to Surge with 10.3% CAGR, Says FutureWise Research Futurewise Research
15-Jul-2025 ViiV Healthcare data show 89% of treatment-naïve people with HIV choose to switch to long-acting injectable Vocabria + Rekambys from daily pills after achieving rapid viral suppression ViiV
15-Jul-2025 MSF welcomes the release of WHO guidelines for ‘game-changing’ HIV prevention drug, lenacapavir, but remains deeply concerned about access, including licensing limitations MSF
14-Jul-2025 Avascular Necrosis Market to Reach USD 1.13 Billion by 2033, Fuelled by Advances in Regenerative Therapies and Orthopedic Innovation Ameco Research
14-Jul-2025 End-to-End Regulatory Lifecycle Management Software Freyr Solutions
11-Jul-2025 Platelet Rich Plasma Market Expected to Reach USD 2,018.1 Million by 2033, Driven by Regenerative Medicine and Aesthetic Demand - Exclusive By Ameco Research Ameco Research
11-Jul-2025 ISS UK reaches £1 million milestone in apprenticeship levy gifting in 2025 ISS UK
11-Jul-2025 Epitopea Expands its Clinical Development and Research Capabilities as it Accelerates to the Clinic Epitopea
11-Jul-2025 A Life Rewritten: KFSHRC Treats Rare Disease After 22 Years of Specialized Care KFSHRC
11-Jul-2025 Transgene Appoints Seasoned Industry Executive Emmanuelle Quilès to Board of Directors as Independent Director Transgene
10-Jul-2025 Epitopea Expands its Clinical Development and Research Capabilities as it Accelerates to the Clinic Epitopea
10-Jul-2025 Bioengineered Protein Drugs Market Set to Soar with 8.22% CAGR, Says FutureWise Futurewise Research
09-Jul-2025 ViiV Healthcare presents new data demonstrating positive real-world impact of its innovative long-acting injectables for HIV at IAS 2025 ViiV Healthcare
09-Jul-2025 Phesi CEO warns phase 3 trial failures loom as sponsors overlook real-world data and overcrowd investigator sites Phesi
08-Jul-2025 PrimeVigilance Enhances Efficiency and Patient Safety with Oracle Argus Platform PrimeVigilance
08-Jul-2025 Modus Therapeutics completes enrollment in Part 1 of the Phase IIa sevuparin study in chronic kidney disease with anemia Modus Therapeutics
08-Jul-2025 Eleva administers first dose of its Factor H biological treatment in C3-Glomerulopathy to healthy volunteers Eleva
08-Jul-2025 Hyaluronic Acid Dermal Filler Market Poised to Surpass USD 10.8 Billion by 2033 Amid Rising Demand for Minimally Invasive Aesthetic Treatments Ameco Research
07-Jul-2025 First patient dosed in the Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy Pulsesight Therapeutics